Shibing Wang

10PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyMolecular targetsPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 19, 2025
Status and Prospects of Glioblastoma Multiforme Treatments.

Xue Yang, Shibing Wang, Vedrana Montana

|Jul 11, 2025
Hyaluronidase: structure, mechanism of action, diseases and therapeutic targets.

Jiamin Lu, Zheng Zhao, Lingli Pan

|Jan 11, 2025
Oncolytic vaccinia virus armed with anti-CD47 nanobody elicit potent antitumor effects on multiple tumor models via enhancing innate and adoptive immunity.

Zengpeng Li, Mengyuan Li, Liu Yang

|Aug 02, 2024
An Engineered Self-biomineralized Oncolytic Adenovirus Induces Effective Antitumor Immunity and Synergizes With Immune Checkpoint Blockade.

Shibing Wang, Xue Yang, Ying-Yu Ma

|Jul 01, 2022
The correlation of fibrinogen-like protein-1 expression with the progression and prognosis of hepatocellular carcinoma.

Nanni Hua, Anxian Chen, Chen Yang

|Mar 01, 2022
CD19-targeted BiTE expression by an oncolytic vaccinia virus significantly augments therapeutic efficacy against B-cell lymphoma.

Wen Lei, Qian Ye, Yuanyuan Hao

Pageof 2

Frequent Collaborators

2 joint publications

Wenbin Qian

2 joint publications

Xue Yang

1 joint publications

Shufang Xie

1 joint publications

Ying-Yu Ma